Theratechnologies adds Gary Littlejohn to its Board as Independent Director

– CANADA, Montreal – Theratechnologies Inc. (TSX: TH) today announced the appointment of Gary Littlejohn as a new independent member to its Board of Directors.

“Gary brings a diversified background and expertise and he will bring additional strength to the Board at a time when the Company is growing,” said Mrs. Dawn Svoronos, Chair of the Board, Theratechnologies Inc.

“As I mentioned during our last Annual General Meeting, the Board concluded that, given the transformation and the growth of the Company, it was time to have additional board members,” added Mrs. Svoronos.

About Gary Littlejohn

From 2008 to 2015, Mr. Littlejohn held the position of CEO and then of advisor to the Chairman and Board Member of the Arab National Investment Company, also known as ANB Invest, in Riyadh, a subsidiary of Arab National Bank. Previously, he was Managing Director of investment banking at Desjardins Securities in Montreal, a position he took after serving six years as Executive Vice-president at Ecopia Biosciences. Mr. Littlejohn also occupied various senior positions in investment banking at TD Securities, Midland Walwyn, BMO Nesbitt Burns and National Bank Financial. Most recently, he held the position of Interim CEO at Helix BioPharma.

Mr. Littlejohn also served on the Board of several corporations including Helix BioPharma, ANB Invest, Aegera Pharmaceuticals, Ecopia Biosciences and The Montreal Exchange.

Mr. Littlejohn holds a B.A. (Honours Economics), a BCL and a MBA from McGill University. He also completed the Director Education Program provided by the Canadian Institute of Corporate Directors in 2016. He is a retired advocate of the Quebec Bar.

About Theratechnologies

Theratechnologies (TSX: TH) is a specialty pharmaceutical company addressing unmet medical needs by bringing to market specialized therapies for people with orphan medical conditions, including those living with HIV.

For more information : http://www.theratech.com

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.

Talent4Boards Team

here the original post =>